Medical Health & Life Science Research News

New report examines the diarrhea therapeutic and drug pipeline review

New report examines the diarrhea therapeutic and drug pipeline review

Diarrhea Therapeutic and Drug Pipeline Review H2

- Advertisement -

- Restart your WhaTech membership at anytime. -

Summary

Diarrhea Make an Inquiry about this news is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning.

Symptoms include nausea, abdominal pain, cramping, bloating, dehydration, fever, bloody stools, frequent urge to evacuate the bowels and incontinence. Treatment includes medication and healthy lifestyle.

- Advertisement -

- Restart your WhaTech membership at anytime. -

Report: www.wiseguyreports.com/sample-requ…ne-review-h2-2017 Make an Inquiry about this news

Report Highlights

Pharmaceutical and Healthcare latest pipeline guide Diarrhea - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Diarrhea (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Diarrhea (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Diarrhea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 7, 10, 2, 1, 21 and 4 respectively.

Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 2 and 4 molecules, respectively.

Diarrhea (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Diarrhea (Gastrointestinal).

- The pipeline guide reviews pipeline therapeutics for Diarrhea (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Diarrhea (Gastrointestinal) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Diarrhea (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Diarrhea (Gastrointestinal)

Reasons to access

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Diarrhea (Gastrointestinal).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Diarrhea (Gastrointestinal) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Content: Key Points

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Diarrhea - Overview 7

Diarrhea - Therapeutics Development 8

Pipeline Overview 8

Pipeline by Companies 9

Pipeline by Universities/Institutes 13

Products under Development by Companies 14

Products under Development by Universities/Institutes 17

Diarrhea - Therapeutics Assessment 18

Assessment by Target 18

Assessment by Mechanism of Action 21

Assessment by Route of Administration 23

Assessment by Molecule Type 25

Diarrhea - Companies Involved in Therapeutics Development 27

  1. Menarini Industrie Farmaceutiche Riunite Srl 27

Actelion Ltd 27

Aegis Therapeutics LLC 28

Akthelia Pharmaceuticals Ltd 28

Albireo Pharma Inc 29

Allergan Plc 29

Anatara Lifesciences Limited 30

Ardelyx Inc 30

Assembly Biosciences Inc 31

AzurRx BioPharma Inc 31

Bharat Biotech International Ltd 32

Cosmo Pharmaceuticals NV 32

DiscoveryBiomed Inc 33

GP Pharm SA 33

Miyarisan Pharmaceutical Company Ltd 34

Mucosis BV 34

…Continued        

 

ACCESS REPORT at www.wiseguyreports.com/reports/157…ne-review-h2-2017 Make an Inquiry about this news   

                                 

News From

Wise Guy Reports - Market ResearchWise Guy Reports
Category: Market Research Publishers and RetailersCompany profile: Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs. Our Market Research Reports and Consulting Services  ...

For more information:

Make an Inquiry about this report HERE!
  • www.wiseguyreports.com/reports/157…ne-review-h2-2017
  • www.wiseguyreports.com/sample-requ…ne-review-h2-2017
  • www.wiseguyreports.com/conferences
  • www.wiseguyreports.com/seminars